May 4, 2005 (updated May 5, 2005) — Editor's Note: On April 29, Amylin Pharmaceuticals, Inc., and Eli Lilly and Co. announced that the U.S. Food and Drug Administration (FDA) had approved exenatide ...

Treatment with the diabetes drug exenatide was associated with a significant decrease in hyperglycemia in acute stroke patients, a new study shows. The research could offer clinicians an alternative ...

Exenatide is a generic prescription drug approved to help manage blood sugar levels in adults with type 2 diabetes. It’s not available in a brand-name version. Exenatide comes as a liquid solution ...

A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier 'proof of concept' clinical trial using exenatide showed that improvements persisted 12 months after ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA approved exenatide in April 2005 and it was the ...

Seven years after receiving a kidney transplant, a 44-year old woman with a 31-year history of type 1 diabetes mellitus and long-term complications (retinopathy, neuropathy, and end-stage renal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with very poorly controlled type 2 diabetes ...

LOS ANGELES, CA—The experimental agent exenatide appears cardioprotective in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI), ...

As an adjunct to primary percutaneous coronary intervention (PCI), the experimental agent exenatide is cardioprotective in patients with ST-segment elevation myocardial infarction (STEMI)—but only in ...

A follow-up study of patients with Parkinson’s disease (PD) who participated in an earlier “proof of concept” clinical trial using exenatide showed that improvements persisted twelve months after ...